Company

SiNuo New Drugs

SiNuo New Drugs develops radiopharmaceuticals for diagnostic imaging and treatment.

About

Nanjing SiNuo New Drug R&D Co., Ltd., doing business as SiNuo New Drugs, develops radiopharmaceuticals, including targeted radioactive isotope-labeled drugs for diagnostic and therapeutic use. Its work spans discovery through preclinical development. Founded in 2021 and based in Nanjing, China, the company raised Series A+ funding from Star Capital in March 2026.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in